No data to show
  • Asia-Pacific Liquid Biopsy Market CAGR of 13.4% during the forecast period of 2023 to 2030.
    Executive Summary Asia-Pacific Liquid Biopsy Market :  Data Bridge Market Research analyzes that the Asia-Pacific liquid biopsy market is expected to grow at a CAGR of 13.4% during the forecast period of 2023 to 2030. The market study of Asia-Pacific Liquid Biopsy Market report helps minimize the risks of uncertainties and helps in taking sound decisions. This market report...
    0 Comments 0 Shares
  • CT Scanner Market Size, Growth Opportunities, Key Drivers and Competitive Outlook
    CT Scanner Market By Type (Stationary CT Scanner, Portable CT Scanner), Device Architecture (C-Arm CT Scanners, O-Arm CT Scanners), Technology (High-Slice CT, Mid-Slice CT, Low-Slice CT, Cone Beam CT), Application (Human Applications, Veterinary Applications, Research Applications), End-Users (Hospitals and Diagnostics Centers, Research Laboratories, Academic Institutes and CROs,...
    0 Comments 0 Shares
  • Global Multiplex Assays Market Analysis: Size, Share and Forecast Opportunities
    Market Overview The multiplex assays market size was valued at USD 4.05 billion in 2024. The market is projected to grow from USD 4.38 billion in 2025 to USD 9.13 billion by 2034, exhibiting a CAGR of 8.5% during 2025–2034. The multiplex assays market is witnessing significant transformation as the demand for rapid, high-throughput, and cost-efficient analytical solutions...
    0 Comments 0 Shares
  • Herpes Simplex Virus Treatment Market: Addressing a Global Viral Challenge
    Introduction The Herpes Simplex Virus Treatment Market is experiencing steady growth due to the high global prevalence of herpes simplex virus (HSV) infections and increasing demand for effective antiviral therapies. Valued at USD 2.8 billion in 2024, the market is projected to reach USD 4.3 billion by 2034, growing at a compound annual growth rate (CAGR) of 5.5%. HSV types 1 and 2,...
    0 Comments 0 Shares
  • Key Players and Market Strategies in Europe Clinical Laboratory Tests
    The Europe Clinical Laboratory Tests Market, valued at USD 68.54 billion in 2024, is expected to grow at a CAGR of 2.21% during 2025–2034, reaching USD 85.21 billion by 2034. The market growth is fueled by the increasing adoption of molecular diagnostics, expansion of laboratory automation, and growing investment in healthcare infrastructure across Europe. The...
    0 Comments 0 Shares
  • Multiplex Molecular Diagnosis Technology Market Growth Opportunities, Key Drivers and Competitive Outlook
    Multiplex Molecular Diagnosis Technology Market, By Product Type (Analyzers, Software, Instruments, Centrifuge, Counting Chambers, Incubators), Method (Real-time PCR, Nested PCR with Melt Curve Analysis, PCR with Low Density Microarray, PCR with Liquid Phase Bead Array, PCR with Electrochemical Detection) – Industry Trends and Forecast to 2029. Data Bridge Market Research analyses that...
    0 Comments 0 Shares
  • Non-Small Cell Lung Cancer Market Overview, Growth Analysis, Trends and Forecast By 2030
    "Executive Summary Non-Small Cell Lung Cancer Market : Data Bridge Market Research analyses that the non-small cell lung cancer market which is USD 26948.36 million in 2022, is expected to reach USD 76334.72 million by 2030, at a CAGR of 13.9% during the forecast period 2023 to 2030. The Non-Small Cell Lung Cancer Market research report concentrates on the foremost competitors of...
    0 Comments 0 Shares
  • Oncology-Based Molecular Diagnostics Market Set to Hit USD 6.12 Billion by 2034, Fueled by Precision Medicine and Biomarker Advancements
    Market Overview The global oncology-based molecular diagnostics market is witnessing steady and sustained growth, reflecting the growing role of molecular-level technologies in transforming cancer care. Valued at USD 3.66 billion in 2024, the market is projected to reach USD 6.12 billion by 2034, expanding at a CAGR of 5.3% from 2025 to 2034. This growth trajectory...
    0 Comments 0 Shares
No data to show
No data to show
No data to show
No data to show